Cannabis spray wins approval
A cannabis-based medicine formulated by a UK company to help sufferers of multiple sclerosis has been approved for use for the first time in Canada. GW Pharmaceuticals and Bayer HealthCare announced
A cannabis-based medicine formulated by a UK company to help sufferers of multiple sclerosis has been approved for use for the first time in Canada. GW Pharmaceuticals and Bayer HealthCare announced